AGF Investments Inc’s Novavax NVAX Stock Holding History

AGF Investments Inc’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-744	Closed	-$135K	–	790
2021 Q1	$135K	Sell	744 -1,332	-64%	-$265K	﹤0.01%	691
2020 Q4	$231K	Buy	+2,076	New	+$221K	﹤0.01%	555

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AGF Investments Inc's NVAX Position: Q2 2021 in Review

AGF Investments Inc sold out of Novavax (NVAX) in Q2 2021, closing a stake of 744 shares — an estimated $135K sold.

AGF Investments Inc first reported a position in NVAX in Q4 2020 and held it in 2 quarters. The position peaked at $231K in Q4 2020. 407 funds tracked by Wall St. Rank hold NVAX as of Q2 2021.

AGF Investments Inc reported no remaining Novavax position as of Q2 2021 after selling out during the quarter.
AGF Investments Inc sold 744 Novavax shares in Q2 2021, an estimated $135K.
AGF Investments Inc first reported a position in Novavax in Q4 2020 and held it in 2 quarters.
AGF Investments Inc's Novavax position peaked at $231K in Q4 2020.
407 funds tracked by Wall St. Rank held Novavax as of Q2 2021.

Based on AGF Investments Inc's 13F filing for Q2 2021, filed 10 Aug 2021.